fashion -WSS

fashion

author：entertainment 2025-09-28 21:05:52 - browse：34

The future looks even brighter for the blockbuster Enhertu, showcased here at ASCO. ADAM FEUERSTEIN/STAT

CHICAGO — The cancer drug Enhertu stalled the growth of tumors by more than a year, significantly longer than standard chemotherapy did in women with the most common form of metastatic breast cancer — a clinical trial result that once again promises to rewrite the rules for the treatment of the disease.

The makers of Enhertu, Daiichi Sankyo and AstraZeneca, said the new data, if cleared by regulators, could shift the way physicians treat hormone receptor-positive, metastatic breast cancer, and create a new standard of care in which patients with breast tumors that express even the faintest amount of HER2 protein can benefit.

“It’s not an overestimation to say that trastuzumab deruxtecan is the most potent drug ever developed for breast cancer,” said Paolo Tarantino, a medical oncologist at the Dana-Farber Cancer Institute, using the scientific name for Enhertu. “It does come with side effects that we’re learning to manage, but with that said, I’ve never seen data like what’s being reported here.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Does Medicare's free annual wellness visit do any good?

leisure time

WSS

California Joshua trees severely burned in massive wildfire

Mike Pence clashes with Tucker Carlson in Iowa

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Medical mystery: When an infection after surgery isn’t what it seems

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Special counsel alerts court to Trump’s social media post

Medicare proposal to cover medical devices draws a mixed reaction

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

DIEP, the 'gold standard' of breast reconstruction, is under threat

New company forms to vet health AI models, root out weaknesses

Hepatitis C has a cure — but many Americans still lack access to it

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

New air purifier tech could be key to improving indoor air quality

Federal judge rules Oregon’s tough new gun law is constitutional

entertainment

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Slain Parkland victim's father speaks out following reenactment

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Does aspartame cause cancer? What new WHO guidance says

leisure time

Wikipedia

leisure time

Wikipedia